These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
600 related articles for article (PubMed ID: 16756999)
21. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease. Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022 [TBL] [Abstract][Full Text] [Related]
22. Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms. Elmer L; Schwid S; Eberly S; Goetz C; Fahn S; Kieburtz K; Oakes D; Blindauer K; Salzman P; Oren S; Prisco UL; Stern M; Shoulson I; ; J Neurol Sci; 2006 Oct; 248(1-2):78-83. PubMed ID: 16828804 [TBL] [Abstract][Full Text] [Related]
23. The effects of acute tryptophan depletion on neuropsychological function, mood and movement in the healthy elderly. Mace JL; Porter RJ; Dalrymple-Alford JC; Wesnes KA; Anderson TJ J Psychopharmacol; 2011 Oct; 25(10):1337-43. PubMed ID: 21262857 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge. Jagannathan V; Venitz J Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784 [TBL] [Abstract][Full Text] [Related]
25. Does implicit learning in non-demented Parkinson's disease depend on the level of cognitive functioning? Vandenbossche J; Deroost N; Soetens E; Kerckhofs E Brain Cogn; 2009 Feb; 69(1):194-9. PubMed ID: 18715683 [TBL] [Abstract][Full Text] [Related]
26. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease. Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P; Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842 [TBL] [Abstract][Full Text] [Related]
27. Maintenance of response readiness in patients with Parkinson's disease: evidence from a simple reaction time task. Stern ER; Horvitz JC; Côté LJ; Mangels JA Neuropsychology; 2005 Jan; 19(1):54-65. PubMed ID: 15656763 [TBL] [Abstract][Full Text] [Related]
28. Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson's disease. Perbal S; Deweer B; Pillon B; Vidailhet M; Dubois B; Pouthas V Brain Cogn; 2005 Jun; 58(1):35-48. PubMed ID: 15878725 [TBL] [Abstract][Full Text] [Related]
29. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations. Imamura K; Wada-Isoe K; Kitayama M; Nakashima K Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890 [TBL] [Abstract][Full Text] [Related]
30. Visual dysfunction in Parkinson disease without dementia. Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276 [TBL] [Abstract][Full Text] [Related]
32. Motor program memory storage in Parkinson's disease patients tested with a delayed response task. Labutta RJ; Miles RB; Sanes JN; Hallett M Mov Disord; 1994 Mar; 9(2):218-22. PubMed ID: 8196687 [TBL] [Abstract][Full Text] [Related]
33. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease? van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551 [TBL] [Abstract][Full Text] [Related]
34. Side of onset of motor symptoms influences cognition in Parkinson's disease. Tomer R; Levin BE; Weiner WJ Ann Neurol; 1993 Oct; 34(4):579-84. PubMed ID: 8215246 [TBL] [Abstract][Full Text] [Related]
35. Relationship between memory strategies and motor symptoms in Parkinson's disease. Berger HJ; van Es NJ; van Spaendonck KP; Teunisse JP; Horstink MW; van 't Hof MA; Cools AR J Clin Exp Neuropsychol; 1999 Oct; 21(5):677-84. PubMed ID: 10572286 [TBL] [Abstract][Full Text] [Related]
36. Global Mobility Task: index for evaluating motor impairment and motor rehabilitation programs in Parkinson's disease patients. Peppe A; Ranaldi A; Chiavalon C; Gasbarra A; Collepardo A; Romeo R; Pasqualetti P; Caltagirone C Acta Neurol Scand; 2007 Sep; 116(3):182-9. PubMed ID: 17714332 [TBL] [Abstract][Full Text] [Related]
37. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease. Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611 [TBL] [Abstract][Full Text] [Related]